![Kevin Grainger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Kevin Grainger is the founder of EOS Syndicate Management Ltd. founded in 2014.
He is currently a Director at 3F BIO Ltd. since 2017 and a Director at ILC Therapeutics Ltd. since 2015.
Kevin Grainger active positions
| Companies | Position | Start |
|---|---|---|
3F BIO Ltd.
 3F BIO Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research | Director/Board Member | 2017-06-30 |
EOS Syndicate Management Ltd.
 EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Founder | 2013-12-31 |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Director/Board Member | 2015-07-14 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Finance |
3F BIO Ltd.
3F BIO Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research | Commercial Services |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
- Stock Market
- Insiders
- Kevin Grainger
